Literature DB >> 11556815

Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human.

V Aumont1, S Krisa, E Battaglia, P Netter, T Richard, J M Mérillon, J Magdalou, N Sabolovic.   

Abstract

Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenol present in wine, which has been reported to have anti-inflammatory, anti-platelet, and anti-carcinogenic effects. The glucuronidation of this compound and that of the cis-isomer also naturally present, has been investigated in human liver microsomes. Both isomers were actively glucuronidated. The reaction led to the formation of two glucuronides (3-O- and 4'-O-glucuronides), whose structure was characterized by LC-MS and proton NMR. Glucuronidation was regio- and stereoselective. It occurred at a faster rate with the cis-isomer and preferred the 3-position on both isomers. In addition, the glucuronidation of resveratrol was tested using several recombinant UDP-glucuronosyltransferase (UGT) isoforms. The reaction was catalyzed by UGT of the family 1A (UGT1A1, 1A6, 1A7, 1A9, 1A10). The bilirubin conjugating UGT1A1 was mainly involved in the 3-O-glucuronidation of trans-resveratrol, whereas the phenol conjugating UGT1A6 activity was restricted to cis-resveratrol. The UGT1A9 and 1A10 were active toward both isomers. The activity supported by UGT2B7 and UGT2B15 was very low and restricted to cis-resveratrol. UGT1A3, 1A4, 2B4, and 2B11 were unable to form resveratrol glucuronides. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556815     DOI: 10.1006/abbi.2001.2496

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  16 in total

1.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

Review 2.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

3.  Resveratrol and exercise.

Authors:  Saltuk Bugra Baltaci; Rasim Mogulkoc; Abdulkerim Kasim Baltaci
Journal:  Biomed Rep       Date:  2016-10-11

4.  Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites.

Authors:  Alexandra Maier-Salamon; Birgit Hagenauer; Michael Wirth; Franz Gabor; Thomas Szekeres; Walter Jäger
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

5.  Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells.

Authors:  Otito F Iwuchukwu; Ronald J Tallarida; Swati Nagar
Journal:  Life Sci       Date:  2011-04-03       Impact factor: 5.037

6.  Transport, deglycosylation, and metabolism of trans-piceid by small intestinal epithelial cells.

Authors:  Caroline Henry-Vitrac; Alexis Desmoulière; Delphine Girard; Jean-Michel Mérillon; Stéphanie Krisa
Journal:  Eur J Nutr       Date:  2006-09-28       Impact factor: 5.614

7.  Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences.

Authors:  Ryan W Dellinger; Angela M Gomez Garcia; Frank L Meyskens
Journal:  Drug Metab Pharmacokinet       Date:  2013-08-20       Impact factor: 3.614

8.  Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.

Authors:  Esra Mutlu; Seth T Gibbs; Natalie South; Jessica Pierfelice; Brian Burback; Dori Germolec; Suramya Waidyanatha
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-20       Impact factor: 4.219

Review 9.  The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.

Authors:  Mohamed Ouzzine; Sandrine Gulberti; Nick Ramalanjaona; Jacques Magdalou; Sylvie Fournel-Gigleux
Journal:  Front Cell Neurosci       Date:  2014-10-28       Impact factor: 5.505

10.  Novel resveratrol-based substrates for human hepatic, renal, and intestinal UDP-glucuronosyltransferases.

Authors:  Aleksandra K Greer; Nikhil R Madadi; Stacie M Bratton; Sarah D Eddy; Zofia Mazerska; Howard P Hendrickson; Peter A Crooks; Anna Radominska-Pandya
Journal:  Chem Res Toxicol       Date:  2014-03-11       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.